Intervertebral disc replacement trial

Details for Australian Patent Application No. 2004281165 (hide)

Owner SpineCore, Inc.

Inventors Dudasik, Michael W.; Zubok, Rafail; Errico, Joseph P.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004281165

PCT Pub. Number WO2005/037078

Priority 10/782,131 19.02.04 US; 10/688,632 17.10.03 US

Filing date 15 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 24 June 2010

International Classifications

A61B 17/17 (2006.01) Surgery

A61B 17/80 (2006.01) Surgery

A61F 2/44 (2006.01) Filters - for the spine, e.g. vertebrae, spinal discs

A61F 2/46 (2006.01) Filters - Special tools for implanting artificial joints

A61B 17/70 (2006.01) Surgery - Spinal positioners or stabilisers

A61B 17/86 (2006.01) Surgery

A61B 17/88 (2006.01) Surgery - Methods or means for implanting or extracting internal fixation devices

A61F 2/00 (2006.01) Filters

A61F 2/30 (2006.01) Filters - Joints

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/037078 Priority application(s): WO2005/037078

24 June 2010 Application Accepted

  Published as AU-B-2004281165

22 July 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 09 Jun 2010. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000 2005

18 November 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Jun 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281166-Expandible surgical access device

2004281154-2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of Raf kinase for treatment of cancer